Patent Assignment
Reel/Frame 072096/0735
Assignment of Assignor's Interest
Recorded: 2025-08-22
Pages: 18
Assignors
DAAK, AHMED
Executed: 2024-05-13
GUO, HAILING
Executed: 2024-05-07
LEE, MICHELLE
Executed: 2024-05-07
Assignee
PRINCIPIA BIOPHARMA INC.
100 MORRIS ST., MORRISTOWN, NEW JERSEY, 07960
Covered Property
(1)
Methods for Treating Persistent or Chronic Immune Thrombocytopenia in Children, Adolescents and Adults by Administering (R)-2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)Pyrazolo[3,4-D]Pyrimidin-1-Yl]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-Yl)Piperazin-1-Yl]Pent-2-Enenitrile
Application:
18/756,019 →
Publication:
US 2025/0108054
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.